Follow-The-Filings

Holders · period archive

Tonix Pharmaceuticals Hldg C Com New

Q4 2025 13F holders among managers we track latest ownership dossier

Type
Equity
Class
W
Total reported value ($000, long equity)
Manager Report date Value Shares